These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 4258670)

  • 1. [Age-dependent inhibitor of vaccinia virus in the serum of normal rats].
    Jandásek L; Svobodová M
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jan; 21(1):13-20. PubMed ID: 4258670
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of anti-leucocyte serum on intraperitoneal vaccinia virus infection of rats.
    Jandásek L
    Acta Virol; 1970 Nov; 14(6):467-73. PubMed ID: 4394992
    [No Abstract]   [Full Text] [Related]  

  • 3. Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals.
    de Souza Trindade G; Drumond BP; Guedes MI; Leite JA; Mota BE; Campos MA; da Fonseca FG; Nogueira ML; Lobato ZI; Bonjardim CA; Ferreira PC; Kroon EG
    J Clin Microbiol; 2007 Apr; 45(4):1370-2. PubMed ID: 17287326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia gangrenosa with circulating vaccinial antibodies and benign indolent vaccinal ulceration: case reports and discussion.
    Boughton CR; Hawkes RA; Tait-Smith A
    Med J Aust; 1969 Jan; 1(4):143-9. PubMed ID: 5769729
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of the kinetics of neutralization of the vaccina virus by means of titration of the homologous antiserum.
    Rapicetta M; Mancini G; Santoro R
    Boll Ist Sieroter Milan; 1973; 52(4):315-20. PubMed ID: 4798236
    [No Abstract]   [Full Text] [Related]  

  • 6. 19 S neutralizing antibody produced in guinea pigs by rabies virus.
    Fujisake Y; Sekiguchi K; Hirasawa K
    Natl Inst Anim Health Q (Tokyo); 1968; 8(3):132-9. PubMed ID: 5712546
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel vaccinia-neutralization assay based on reporter-gene expression.
    Manischewitz J; King LR; Bleckwenn NA; Shiloach J; Taffs R; Merchlinsky M; Eller N; Mikolajczyk MG; Clanton DJ; Monath T; Weltzin RA; Scott DE; Golding H
    J Infect Dis; 2003 Aug; 188(3):440-8. PubMed ID: 12870127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunodepressive action of vaccinia virus].
    Daniliuk OS; Dzagurov SG; Berdinskikh MS
    Biull Eksp Biol Med; 1982 Jul; 94(7):73-4. PubMed ID: 6889898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody in tears following intranasal vaccination with inactivated virus. 3. Role of tear and serum antibody in experimental vaccinia conjunctivitis.
    Knopf HL; Blacklow NR; Glassman MI; Cline WL; Wong VG
    Invest Ophthalmol; 1971 Oct; 10(10):760-9. PubMed ID: 4941860
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological relationship of buffalopox virus to vaccinia and cowpox viruses.
    Kataria RS; Singh IP
    Acta Virol; 1970 Jul; 14(4):307-11. PubMed ID: 4394186
    [No Abstract]   [Full Text] [Related]  

  • 12. Some observations on the behavior of vaccinia virus particles with antiserum, particularly their agglutination.
    Galasso GJ; Sharp DG
    J Immunol; 1965 Oct; 95(4):737-42. PubMed ID: 5841056
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immune response after intramuscular administration of vaccinia virus].
    Wurzel R
    Cesk Pediatr; 1973 Nov; 28(11):612-5. PubMed ID: 4769664
    [No Abstract]   [Full Text] [Related]  

  • 14. Zoonotic vaccinia virus: clinical and immunological characteristics in a naturally infected patient.
    Trindade GS; Guedes MI; Drumond BP; Mota BE; Abrahão JS; Lobato ZI; Gomes JA; Corrêa-Oliveira R; Nogueira ML; Kroon EG; da Fonseca FG
    Clin Infect Dis; 2009 Feb; 48(3):e37-40. PubMed ID: 19115976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus peritoneal infection in rats of different ages.
    Jandásek L; Dvorák R; Votava M
    Acta Virol; 1969 Mar; 13(2):88-95. PubMed ID: 4389049
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunity to vaccina virus of Japanese people of different age groups: serum antibody titre and local skin reaction at the site of vaccination.
    Kitaoka M; Nishimura C; Kimura M
    Prog Immunobiol Stand; 1970; 4():683-91. PubMed ID: 5482206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenicity of vaccinia virus for the rat].
    Jandásek L
    Zentralbl Bakteriol Orig; 1968; 207(2):172-7. PubMed ID: 5745202
    [No Abstract]   [Full Text] [Related]  

  • 18. The significance of the challenge strain in the potency assay of the antivaccinia immunoglobulin preparation.
    Nyerges G; Csukás M; Láng Cs
    Dev Biol Stand; 1974; 27():98-101. PubMed ID: 4463129
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification of vaccinia virus by gelfiltration.
    Hedström KG; Lindberg U
    Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 137(5):421-30. PubMed ID: 4239399
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
    Lustig S; Fogg C; Whitbeck JC; Moss B
    Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.